Healthcare & Life Sciences Private Equity Deal Tracker: Linden Acquires Alcresta Therapeutics
JD Supra: Mergers
MARCH 15, 2024
Linden Capital Partners has announced the acquisition of Alcresta Therapeutics. Alcresta, founded in 2011 and based in Newton, Mass., develops and commercializes enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. By: McGuireWoods LLP
Let's personalize your content